Paul Nguyen, M.D., and Toni Choueiri, M.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Paul Nguyen, M.D., and Toni Choueiri, M.D., Dana-Farber Cancer Institute

Caption

A new study by Paul Nguyen, M.D., and Toni Choueiri, M.D., from Dana-Farber/Brigham and Women's Cancer Cente says Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks -- as some recent studies had suggested.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.